A pembrolizumab (Keytruda) combination led to an overall survival (OS) boost in patients with newly diagnosed, previously untreated, high-risk locally advanced cervical cancer, according to results ...
Health Care Utilization and Follow-Up Care in Young Adult Breast Cancer Survivors We performed a nation-wide retrospective matched cohort study of all patients age 18-45 years with Fédération ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results